Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. (COR) is a leading pharmaceutical services company dedicated to ...

Shares of Cencora Inc. COR shed 1.28% to $243.59 Wednesday, on what proved to be an all-around grim trading session for the ...

Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...

Leerink Partnrs dropped their Q2 2025 EPS estimates for Cencora in a report released on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $4.08 per ...

Cencora COR is slated to report first-quarter fiscal 2025 results on Feb. 05, before market open. In the last reported ...

In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive ...

The Trump administration’s moves to trim government spending pose a short-term “understated risk” for companies all across ...

Cencora, Inc (NYSE:COR) reported first-quarter 2025 sales increased 12.8% to $81.5 billion, beating the consensus of $78.38 ...

Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation ...

Angels for Change (A4C) announces the pilot launch of Project GOLD (Generic Oncology Lifesaving Drugs), a new resiliency ...